Your browser doesn't support javascript.
loading
Model-based prediction of effective target exposure for MEN1611 in combination with trastuzumab in HER2-positive advanced or metastatic breast cancer patients.
Tosca, Elena M; Borella, Elisa; Piana, Chiara; Bouchene, Salim; Merlino, Giuseppe; Fiascarelli, Alessio; Mazzei, Paolo; Magni, Paolo.
Afiliação
  • Tosca EM; Laboratory of Bioinformatics, Mathematical Modelling and Synthetic Biology, Department of Electrical, Computer and Biomedical Engineering, Università degli Studi di Pavia, Pavia, Italy.
  • Borella E; Clinical Pharmacology Department, Menarini Stemline, Florence, Italy.
  • Piana C; Clinical Pharmacology Department, Menarini Stemline, Florence, Italy.
  • Bouchene S; Clinical Pharmacology Department, Menarini Stemline, Florence, Italy.
  • Merlino G; Experimental and Translational Oncology Department, Menarini Stemline, Pomezia, Italy.
  • Fiascarelli A; Experimental and Translational Oncology Department, Menarini Stemline, Pomezia, Italy.
  • Mazzei P; Clinical Pharmacology Department, Menarini Stemline, Florence, Italy.
  • Magni P; Laboratory of Bioinformatics, Mathematical Modelling and Synthetic Biology, Department of Electrical, Computer and Biomedical Engineering, Università degli Studi di Pavia, Pavia, Italy.
CPT Pharmacometrics Syst Pharmacol ; 12(11): 1626-1639, 2023 Nov.
Article em En | MEDLINE | ID: mdl-36793223
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article